NASDAQ:NXL Nexalin Technology (NXL) Stock Price, News & Analysis $4.87 -0.18 (-3.56%) Closing price 04:00 PM EasternExtended Trading$4.88 +0.01 (+0.21%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About Nexalin Technology Stock (NASDAQ:NXL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Nexalin Technology alerts:Sign Up Key Stats Today's Range$4.62▼$5.1350-Day Range$4.79▼$14.7452-Week Range$4.51▼$60.00Volume57,270 shsAverage Volume11,138 shsMarket Capitalization$3.56 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Nexalin Technology, Inc. is a U.S.-based medical device company specializing in noninvasive neuromodulation therapies for mental health conditions. The company develops and markets the Nexalin® medical device platform, which delivers proprietary alternating current waveforms to targeted areas of the brain through forehead-mounted electrodes. Its technology is designed to modulate neural activity without pharmaceuticals, positioning the company within the growing field of digital therapeutics and neurostimulation. The Nexalin device has received U.S. Food and Drug Administration 510(k) clearance for the treatment of generalized anxiety disorder and is marketed to healthcare providers, including psychiatrists, primary care physicians and behavioral health clinics. The therapy protocol typically involves a series of short, in-office treatment sessions during which patients remain awake and alert. Nexalin also supports ongoing clinical research to explore additional applications such as depression and stress-related conditions. Headquartered in the United States, Nexalin Technology distributes its devices and training programs through a network of authorized dealers and directly to healthcare institutions. The company focuses on expanding adoption among mental health professionals by combining its regulatory-cleared device with physician training, clinical support services and patient education materials. As interest grows in nonpharmacological approaches to mental health, Nexalin aims to broaden its footprint across outpatient clinics and other care settings nationwide.AI Generated. May Contain Errors. Read More Nexalin Technology Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks23rd Percentile Overall ScoreNXL MarketRank™: Nexalin Technology scored higher than 23% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingNexalin Technology has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageNexalin Technology has only been the subject of 1 research reports in the past 90 days.Read more about Nexalin Technology's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Nexalin Technology is -0.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nexalin Technology is -0.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNexalin Technology has a P/B Ratio of 0.81. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.24% of the float of Nexalin Technology has been sold short.Short Interest Ratio / Days to CoverNexalin Technology has a short interest ratio ("days to cover") of 1.37, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nexalin Technology has recently decreased by 96.01%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNexalin Technology does not currently pay a dividend.Dividend GrowthNexalin Technology does not have a long track record of dividend growth. News and Social Media3.0 / 5News Sentiment0.83 News SentimentNexalin Technology has a news sentiment score of 0.83. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Nexalin Technology this week, compared to 2 articles on an average week.Search Interest5 people have searched for NXL on MarketBeat in the last 30 days. This is an increase of 150% compared to the previous 30 days.MarketBeat Follows1 people have added Nexalin Technology to their MarketBeat watchlist in the last 30 days. Company Ownership0.6 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Nexalin Technology insiders have not sold or bought any company stock.Percentage Held by Insiders16.94% of the stock of Nexalin Technology is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions0.65% of the stock of Nexalin Technology is held by institutions.Read more about Nexalin Technology's insider trading history. Receive NXL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nexalin Technology and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NXL Stock News HeadlinesNexalin Technology Announces New Secondary Analysis of Previously Published Clinical Trial Data Reveals Previously Unreported Improvements in Memory, Comprehension and Language ...September 3, 2026 | markets.businessinsider.comNexalin Reports New Cognitive Improvements In Alzheimer's Analysis, Plans U.S. Pilot StudySeptember 3, 2026 | rttnews.comA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.September 10 at 1:00 AM | Porter & Company (Ad)Nexalin Technology Announces New Secondary Analysis of Previously Published Clinical Trial Data Reveals Previously Unreported Improvements in Memory, Comprehension and Language Function in Alzheimer's Patients; ADAS-Cog Subscale Analysis to Guide Design of Planned U.S. Alzheimer's Pilot StudySeptember 3, 2026 | globenewswire.comNexalin Technology Announces Key Executive Leadership DepartureSeptember 2, 2026 | tipranks.comNexalin Technology, Inc.: Nexalin Technology Announces Reverse Stock SplitAugust 27, 2026 | finanznachrichten.deNexalin Technology Announces 1-for-30 Reverse Stock Split to Maintain Nasdaq ComplianceAugust 27, 2026 | quiverquant.comQNexalin Technology Announces Reverse Stock SplitAugust 27, 2026 | globenewswire.comSee More Headlines NXL Stock Analysis - Frequently Asked Questions How have NXL shares performed this year? Nexalin Technology's stock was trading at $16.74 on January 1st, 2026. Since then, NXL shares have decreased by 70.9% and is now trading at $4.87. How were Nexalin Technology's earnings last quarter? Nexalin Technology, Inc. (NASDAQ:NXL) announced its quarterly earnings results on Wednesday, August, 12th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($3.00) by $2.89. The company earned $0.01 million during the quarter, compared to analysts' expectations of $0.09 million. Nexalin Technology had a negative net margin of 4,141.94% and a negative trailing twelve-month return on equity of 278.24%. When did Nexalin Technology's stock split? Shares of Nexalin Technology reverse split on Monday, August 31st 2026.A 1-30 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, August 30th 2026. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. When did Nexalin Technology IPO? Nexalin Technology (NXL) raised $14 million in an IPO on Friday, September 16th 2022. The company issued 2,315,000 shares at $5.00-$7.00 per share. Who are Nexalin Technology's major shareholders? Nexalin Technology's top institutional investors include AWM Investment Company Inc. (3.40%) and PEAK6 LLC (1.09%). Insiders that own company stock include David Owens and Carolyn Hamby Shelton. View institutional ownership trends. How do I buy shares of Nexalin Technology? Shares of NXL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Nexalin Technology own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nexalin Technology investors own include Meta Platforms (META), NVIDIA (NVDA), Intel (INTC), PayPal (PYPL), Advanced Micro Devices (AMD) and DoorDash (DASH). Company Calendar Last Earnings8/12/2026Today9/10/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1w+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 For the last 8 days, NXL's financial health has been in the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:NXL CIK1527352 Webwww.nexalin.com Phone832-260-0222FaxN/AEmployees3Year FoundedN/AProfitability EPS (Trailing Twelve Months)($14.41) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$8.22 million Net Margins-4,141.94% Pretax Margin-4,142.40% Return on Equity-278.24% Return on Assets-218.42% Debt Debt-to-Equity RatioN/A Current Ratio1.25 Quick Ratio1.10 Sales & Book Value Annual Sales$300 thousand Price / Sales11.85 Cash FlowN/A Price / Cash FlowN/A Book Value$6.03 per share Price / Book0.81Miscellaneous Outstanding Shares730,000Free Float610,000Market Cap$3.56 million OptionableNot Optionable Beta3.95 The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:NXL) was last updated on 9/10/2026 by MarketBeat.com Staff. From Our PartnersShocking AI prediction from the “Billionaire Whisperer"Marc Chaikin's Power Gauge system flagged Micron before it soared 970 percent, Celestica before a 6,600 percen...Chaikin Analytics | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThis looks like plywood. It's not.AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more e...Eagle Publishing | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredElon Musk’s Hushed FCC Filing. Sept 25th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | SponsoredBlackRock and Vanguard already own THISInstitutions own roughly 88 percent of an overlooked American oil and natural gas company. BlackRock holds 32 ...Monument Traders Alliance | SponsoredMusk says UBI is coming. I say it's already here.Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...Freedom Financial | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexalin Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nexalin Technology With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
